Abstract |
Insulinoma is a rare neuroendocrine tumor that overproduces insulin, resulting in hypoglycemic symptoms. Elevated C-peptide levels in the absence of sulfonylurea use indicate insulinoma. Treatment is usually glucose administration and if the tumor size is large, surgery may be warranted. We present a case of a young man who had a one-year continuing episode of hypoglycemic symptoms that resolve after consuming high- glucose solids and liquids. Although symptoms pointed toward insulinoma, the 72-hour fasting test failed to show insulinoma. This case shows how following the algorithm accurately will prevent an inaccurate diagnosis.
|
Authors | Siddharth Shah, Christian Scott, ShahZeib Syed, Safia Afaq, Priscilla Fujikawa |
Journal | Cureus
(Cureus)
Vol. 15
Issue 5
Pg. e38697
(May 2023)
ISSN: 2168-8184 [Print] United States |
PMID | 37292547
(Publication Type: Case Reports)
|
Copyright | Copyright © 2023, Shah et al. |